Genstar Capital adds to strategic advisory board

Genstar Capital has named Harry Totonis to its strategic advisory board. Previously, Totonis worked at Surescripts where he served as president and CEO.

PRESS RELEASE

SAN FRANCISCO, June 16, 2014 – Genstar Capital, a leading middle market private equity firm that focuses on investments in targeted segments of healthcare, software, financial services, and industrial technology industries, today announced the appointment of Harry Totonis, an experienced leader with a nearly 30 year track-record of success, to the firm’s Strategic Advisory Board (SAB).
Mr. Totonis most recently served as President and CEO of Surescripts, the Nation’s largest e-prescribing and clinical information exchange network, since 2009. Prior to that, he was Group Executive at MasterCard Worldwide from 2004 – 2009 and from 2000 – 2004 he served as President and CEO of Kinexus. He began his professional career at Booz Allen & Hamilton and, during his 15 years there, Mr. Totonis focused on strategy consulting for large global companies at a CEO level. He is a graduate of The Ohio State University and received an MBA in finance from Fisher College at Ohio State University.
“Our Strategic Advisory Board includes an expert team of knowledgeable and successful executives whose experience, expertise and relationship network help us capitalize on new opportunities and manage our portfolio,” said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. “As we continue to expand our portfolio of investments we are pleased to further augment the talents of our investment professionals with seasoned executives who have held senior leadership positions at prominent companies matched to our investment focus. The business insights Harry has gained during his extensive career will be very impactful, and we look forward to working with him.”
Genstar Capital’s Strategic Advisory Board provides portfolio companies with a rich source of operating experience and strategic insight, in addition to advising the firm on our investments. The SAB is composed of influential senior executives who are current or former leaders of major corporations. These executives work directly with Genstar Capital and its portfolio companies—sometimes as Board members—to develop strategic plans, expand market opportunities, source acquisitions and recruit executives and board members. Genstar’s 20-member SAB includes executives who served in senior capacities with such leading companies as Abbott Laboratories, Andersen Consulting, UnitedHealthcare, CNA Insurance Companies, ITT Corporation, Oracle, Ingersoll Rand, Marshall & Swift, MedImmune, WellPoint, Russell Investments, Siebel Systems, USI, Vertifore and ICOS Corporation.
About Genstar Capital, LLC
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 20 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating executives and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $2.6 billion of committed capital under management and targets investments focused on selected sectors within healthcare, software, financial services and industrial technology industries.

Leave a Reply

PEHUB Community

Join the 12504 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget